“Nail Outcome Improvements With Certolizumab Pegol in Moderate to Severe Plaque Psoriasis: Results from Phase 3 Trials”. SKIN The Journal of Cutaneous Medicine, vol. 3, Nov. 2019, p. S38, https://doi.org/10.25251/skin.3.supp.38.